rilpivirine/emtricitabine/tenofovir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rilpivirine/emtricitabine/tenofovir, covering 2021-03-17 to 2021-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir [Phase 2, Phase 3]